Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Atlanta Braves C | BATRK | Jan 15, 2025 | 37.10 | +2.23 |
Atlantic American | AAME | Jan 15, 2025 | 1.52 | -1.30 |
Atlantic International | ATLN | Jan 15, 2025 | 4.50 | 0.00 |
Atlantic Union Bank | AUB | Jan 15, 2025 | 38.12 | +1.03 |
Atlantic Union Bankshares A Pref | AUB-A | Jan 15, 2025 | 24.81 | +1.27 |
Atlanticus | ATLC | Jan 15, 2025 | 59.05 | +4.11 |
Atlanticus B Pref | ATLCP | Jan 15, 2025 | 22.92 | -0.79 |
Atlas Energy Solutions | AESI | Jan 15, 2025 | 23.93 | +5.19 |
Atlas Lithium | ATLX | Jan 15, 2025 | 6.98 | +0.87 |
Atlas Pref D | ATCO-D | Jan 15, 2025 | 25.20 | -0.59 |
Atlas Pref H | ATCO-H | Jan 15, 2025 | 25.12 | +0.16 |
AtlasClear | ATCH | Jan 15, 2025 | 6.50 | -7.07 |
Atlassian A | TEAM | Jan 15, 2025 | 250.03 | +1.47 |
Atmos Energy | ATO | Jan 15, 2025 | 141.08 | +0.26 |
Atmus Filtration Technologies | ATMU | Jan 15, 2025 | 41.24 | +0.41 |
ATN International | ATNI | Jan 15, 2025 | 15.32 | +1.39 |
Atomera | ATOM | Jan 15, 2025 | 11.17 | +20.11 |
Atossa Therapeutics | ATOS | Jan 15, 2025 | 0.87 | -0.49 |
Atour Lifestyle ADR | ATAT | Jan 15, 2025 | 25.35 | +0.60 |
ATRenew A ADR | RERE | Jan 15, 2025 | 2.47 | +1.65 |
AtriCure | ATRC | Jan 15, 2025 | 36.97 | +6.57 |
ATS Corporation | ATS | Jan 15, 2025 | 26.53 | +0.15 |
aTyr Pharma | ATYR | Jan 15, 2025 | 3.46 | +5.17 |
Auburn National Bank | AUBN | Jan 15, 2025 | 21.99 | +2.28 |
Auddia | AUUD | Jan 15, 2025 | 0.47 | -2.30 |
AudioCodes | AUDC | Jan 15, 2025 | 10.75 | +1.70 |
AudioEye | AEYE | Jan 15, 2025 | 16.22 | +6.33 |
Auna S.A.A | AUNA | Jan 15, 2025 | 7.44 | -3.38 |
Aura Biosciences | AURA | Jan 15, 2025 | 7.73 | +2.25 |
Aura FAT Projects Acquisition A | AFAR | Jan 15, 2025 | 11.68 | 0.00 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.